Primecap Management Co. CA lessened its holdings in Waters Co. (NYSE:WAT - Free Report) by 29.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 69,041 shares of the medical instruments supplier's stock after selling 29,418 shares during the quarter. Primecap Management Co. CA owned 0.12% of Waters worth $25,613,000 as of its most recent SEC filing.
Other hedge funds also recently made changes to their positions in the company. Bank of Jackson Hole Trust bought a new stake in Waters in the fourth quarter valued at $34,000. Fortitude Family Office LLC lifted its stake in Waters by 235.7% in the fourth quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier's stock valued at $35,000 after buying an additional 66 shares in the last quarter. Steward Partners Investment Advisory LLC increased its position in shares of Waters by 129.3% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier's stock worth $35,000 after acquiring an additional 53 shares in the last quarter. EverSource Wealth Advisors LLC raised its holdings in shares of Waters by 54.3% during the fourth quarter. EverSource Wealth Advisors LLC now owns 125 shares of the medical instruments supplier's stock worth $46,000 after acquiring an additional 44 shares during the period. Finally, R Squared Ltd bought a new stake in Waters in the 4th quarter valued at $63,000. Institutional investors and hedge funds own 94.01% of the company's stock.
Analysts Set New Price Targets
WAT has been the subject of a number of research reports. Sanford C. Bernstein upgraded Waters from a "market perform" rating to an "outperform" rating and set a $430.00 price objective for the company in a report on Friday, January 10th. Barclays upgraded shares of Waters from an "underweight" rating to an "equal weight" rating and increased their target price for the stock from $360.00 to $415.00 in a report on Monday, February 10th. UBS Group raised their price objective on Waters from $405.00 to $410.00 and gave the company a "neutral" rating in a report on Thursday, February 13th. JPMorgan Chase & Co. increased their price target on Waters from $380.00 to $390.00 and gave the company a "neutral" rating in a research report on Thursday, March 6th. Finally, Scotiabank raised Waters from a "sector perform" rating to a "sector outperform" rating and boosted their price target for the stock from $430.00 to $450.00 in a research report on Thursday, February 13th. Eleven investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $391.07.
View Our Latest Stock Report on WAT
Waters Price Performance
NYSE:WAT traded up $7.61 during trading hours on Monday, reaching $373.07. 383,396 shares of the company were exchanged, compared to its average volume of 440,064. The business has a 50 day moving average of $390.80 and a 200 day moving average of $371.56. Waters Co. has a 1-year low of $279.24 and a 1-year high of $423.56. The company has a debt-to-equity ratio of 1.14, a current ratio of 0.94 and a quick ratio of 0.65. The company has a market capitalization of $22.16 billion, a P/E ratio of 34.83, a P/E/G ratio of 3.79 and a beta of 1.00.
Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, beating analysts' consensus estimates of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. Research analysts forecast that Waters Co. will post 12.86 EPS for the current year.
About Waters
(
Free Report)
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Articles
Before you consider Waters, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.
While Waters currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
